A 17-year-old Aboriginal girl from a remote Northern Territory community has a history of rheumatic heart disease with moderate mitral regurgitation. She has been well and is due for routine review. Which regimen is most appropriate for ongoing secondary prophylaxis against recurrent acute rheumatic fever?